|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,677.00 KRW | -1.99% |
|
+7.36% | -27.09% |
| 05-15 | SCL Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-23 | SCL Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 57.04B 40.09M 34.72M 32.36M 29.77M 56.19M 3.81B 56.82M 380M 149M 1.91B 151M 147M 6.32B | P/E 2024 |
-16x | P/E 2025 | -19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 79.58B 55.92M 48.43M 45.15M 41.52M 78.39M 5.32B 79.27M 531M 208M 2.66B 210M 205M 8.81B | EV / Sales 2024 |
13.3x | EV / Sales 2025 | 4.57x |
| Free-Float |
45.72% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.99% | ||
| 1 week | +7.36% | ||
| Current month | +4.03% | ||
| 1 month | -1.29% | ||
| 3 months | -15.86% | ||
| 6 months | -21.82% | ||
| Current year | -27.09% |
| 1 week | 1,429 |  | 1,750 |
| 1 month | 1,389 | | 1,946 |
| Current year | 1,389 | | 2,680 |
| 1 year | 1,389 | | 3,250 |
| 3 years | 1,389 | | 5,110 |
| 5 years | 1,389 | | 5,110 |
| 10 years | 1,300 | | 6,950 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyung-Yul Lee
CEO | Chief Executive Officer | - | 28/12/2022 |
Se-Yeon Baek
CEO | Chief Executive Officer | 59 | 30/09/2024 |
Dae-Young Kim
AUD | Comptroller/Controller/Auditor | 63 | 28/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Se-Yeon Baek
BRD | Director/Board Member | 59 | 30/09/2024 |
Jeong-Gyun Choi
BRD | Director/Board Member | 59 | 30/09/2024 |
Kyung-Yul Lee
BRD | Director/Board Member | - | 28/12/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/25 A | Free | 12,798 | 0.0377% | |||
| 8/11/25 A | Free | Chief Executive Officer | 28,500 | 0.0840% | ||
| 8/11/25 A | Free | 1,359 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.99% | +7.36% | -38.57% | -18.69% | 40.78M | |
| +0.91% | +10.56% | +34.91% | -0.76% | 75.96B | |
| +2.64% | -8.65% | +22.67% | +186.79% | 49.03B | |
| +1.02% | -3.74% | -7.47% | +21.83% | 47.88B | |
| +1.42% | +9.32% | -50.68% | -50.72% | 43.39B | |
| -0.76% | -0.95% | +55.95% | -23.59% | 30.8B | |
| -0.38% | -5.22% | +55.00% | +85.60% | 24.45B | |
| -0.98% | +3.60% | +105.50% | -44.22% | 22.75B | |
| +4.15% | +0.44% | -2.80% | +175.30% | 19.24B | |
| -0.09% | -1.64% | +66.98% | +165.41% | 16.04B | |
| Average | +0.60% | +0.64% | +24.15% | +49.69% | 32.96B | |
| Weighted average by Cap. | +1.01% | +0.59% | +23.34% | +43.48% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.74B 3.33M 2.88M 2.69M 2.47M 4.67M 317M 4.72M 31.58M 12.4M 158M 12.5M 12.23M 525M | 22.01B 15.47M 13.4M 12.49M 11.49M 21.68M 1.47B 21.93M 147M 57.6M 736M 58.09M 56.81M 2.44B |
| Net income | -3.73B -2.62M -2.27M -2.12M -1.95M -3.67M -249M -3.72M -24.87M -9.76M -125M -9.85M -9.63M -413M | -3.93B -2.76M -2.39M -2.23M -2.05M -3.88M -263M -3.92M -26.23M -10.3M -132M -10.38M -10.15M -436M |
| Net Debt | 3.15B 2.21M 1.91M 1.78M 1.64M 3.1M 210M 3.13M 20.97M 8.23M 105M 8.3M 8.12M 348M | 22.53B 15.83M 13.71M 12.78M 11.76M 22.2M 1.51B 22.45M 150M 58.96M 753M 59.47M 58.16M 2.5B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | ₩1,677.00 | -1.99% | 65,861 |
| 04/08/26 | ₩1,711.00 | +4.39% | 91,487 |
| 03/08/26 | ₩1,639.00 | +1.67% | 232,751 |
| 31/07/26 | ₩1,612.00 | +9.21% | 228,504 |
| 30/07/26 | ₩1,476.00 | +2.50% | 102,364 |
- Stock Market
- Stocks
- A246960 Stock
Select your edition
All financial news and data tailored to specific country editions
